Ecnoglutide
A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
Hangzhou Sciwind Biosciences Co · Phase 3 · Completed · Enrollment 664
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| C1- XW003 Low Dosage | Obesity or overweight | n/r | n/r | n/r | n/r |
| C1-Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| C2- XW003 Medium Dosage | Obesity or overweight | n/r | n/r | n/r | n/r |
| C2-Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| C3- XW003 High Dosage | Obesity or overweight | n/r | n/r | n/r | n/r |
| C3-Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |